Guggenheim initiated coverage of Assembly Biosciences (ASMB) with a Buy rating and $31 price target Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed ...

Write to [email protected] Arcus Biosciences NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

SAN DIEGO, March 11, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18 ...

SAN DIEGO, March 20, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the long-term, open-label KINECT ® 4 study demonstrating remission of tardive ...

Uncommon is a pioneering biotechnology company based in the UK working to develop an inexpensive, animal-free culture media designed to produce cultivated meat as an alternative to conventionally ...

Shift Biosciences, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as Translation Advisor and Laurence ...

Colossal Biosciences, known for its outlandish goal to resurrect the woolly mammoth by 2028, is claiming steady progress. Its evidence: genetically engineering mice to have mammoth-like fur.

Colossal Biosciences is aiming to revive extinct species like the woolly mammoth. The startup has raised over $400 million to fund its de-extinction and conservation missions. Its founder and CEO ...

Funding will enable lead candidates CTX114 and CTX203 for AMD to enter clinical trials in the next year JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company ...

The George Church–cofounded de-extinction company, Colossal Laboratories and Biosciences has announced that it has successfully engineered woolly mammoth hair traits into mice. The Colossal ...